Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

0.7380
+0.03805.43%
Post-market: 0.7301-0.0079-1.07%19:59 EDT
Volume:533.97K
Turnover:410.75K
Market Cap:33.04M
PE:-0.95
High:0.8500
Open:0.6800
Low:0.6800
Close:0.7000
52wk High:1.87
52wk Low:0.5011
Shares:44.77M
Float Shares:21.52M
Volume Ratio:1.06
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-2.08
PE(LYR):-0.89

Loading ...

TELA Bio - Withdraws Full Year 2026 Revenue Guidance

THOMSON REUTERS
·
Aug 11

TELA Bio Q2 Basic EPS USD -0.2

THOMSON REUTERS
·
Aug 11

TELA Bio Q2 Operating Expenses USD 23.226 Million

THOMSON REUTERS
·
Aug 11

TELA Bio Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 11

TELA Bio Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 08

TELA Bio CEO, Director Heather Getz Files Initial Beneficial Ownership Statement

Reuters
·
Aug 06

Lake Street Keeps Their Buy Rating on TELA Bio (TELA)

TIPRANKS
·
Aug 04

TELA Bio Appoints Heather Getz CEO, Names Her Director

Reuters
·
Aug 04

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

THOMSON REUTERS
·
Aug 04

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Jul 30

TELA Bio Schedules Quarterly Results Conference Call and Webcast

Reuters
·
Jul 21

TELA Bio director Joseph H. Capper files initial beneficial ownership statement

Reuters
·
Jun 12

TELA Bio director Guy P. Nohra files initial beneficial ownership statement

Reuters
·
Jun 12

TELA Bio Shareholders Expand Equity Incentive Plan Authorization

TIPRANKS
·
Jun 12

TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan

Reuters
·
Jun 12

Lake Street Keeps Their Buy Rating on TELA Bio (TELA)

TIPRANKS
·
May 13

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)

TIPRANKS
·
May 13

TELA Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

TELA Bio posts modest Q1 growth, maintains 2026 outlook

TIPRANKS
·
May 13

TELA Bio Q1 net loss widens to $12.3 million; revenue rises 3% to $19.1 million

Reuters
·
May 13